HOME >> BIOLOGY >> NEWS
High Density Lipoproteins And Coronary Heart Disease

Renowned scientists in the field of lipid research will lead a symposium entitled High Density Lipoproteins and Coronary Heart Disease on Saturday, November 7, 1998 in Dallas, TX. Scientists will review the hypothesis that low levels of high-density lipoprotein (HDL) cholesterol are a risk for coronary heart disease; discuss metabolic disorders that result in this condition; and evaluate treatment options.

The symposium, accredited by Continuing Medical Education at The Johns Hopkins University School of Medicine, will include presentations by:

  • Ernst Schaefer, MD, chief, Lipid Metabolism Laboratory, USDA Human Nutrition Research Center at Tufts University
  • H. Bryan Brewer, MD, chief, Molecular Diseases Branch, National Heart, Lung, and Blood Institute, National Institutes of Health
  • Moti Kashyup, MD, director, Cholesterol Center, Veterans Affairs Medical Center
  • John Guyton, MD, director, Duke Lipid Clinic, Duke University Medical Center
  • Hanna Rubins, MD, associate professor of medicine, University of Minnesota School of Medicine. Dr. Rubins, the Lead Investigator for the High-Density Lipoprotein Intervention Trials (HIT), will be presenting data from HIT on Wednesday, November 11 at 1:00 pm during the American Heart Association Conference.


'"/>

Contact: Karen Peart
k.peart@noonanrusso.com
212-696-4455 ext.343
Noonan/Russo Communications
15-Oct-1998


Page: 1

Related biology news :

1. Study Ensures Effective Ways To Measure Macular Pigment Density
2. Reanalysis Of International Data Finds Sharp Decline In Sperm Density
3. Depression A Risk Factor For Coronary Artery Disease In Men
4. American Heart Association Comment: "Folate And Vitamin B6 From Diet And Supplements In Relation To Risk Of Coronary Heart Disease Among Women"
5. Heart gene yields insights into evolution, disease risk
6. Heartless worms hold clues to cardiac arrhythmias, sudden death
7. Media invited to attend International Society For Heart & Lung Transplantation meeting April 21-24
8. Heart and lung transplantation clinical trial results to be announced at ISHLT meeting
9. Heart may heal with help from oxygen-sensitive genes, new study suggests
10. Heart drug might help fight chronic fungal infections
11. Heart disease among some Japanese may be due to sequencing variation inside a gene

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: High Density Lipoproteins And Coronary Heart Disease

(Date:10/16/2014)... 2014) – Post-menopausal women experienced improvements in vaginal ... or genital bleeding, after 12 weeks of daily ... soy germ-based nutritional supplement previously shown to help ... peer-reviewed pilot study reported in a poster at ... meeting. , "These data documented improved vaginal ...
(Date:10/15/2014)... the pandemic risk from strains of influenza virus increases ... ourselves to become complacent that the most substantial threats ... , Influenza pandemics arise when a new virus strain ... immunity – spreads in the human population. There have ... the worst of which – the 1918 Spanish Flu ...
(Date:10/15/2014)... spreading rapidly and to an unexpected extent. The outbreak ... and the virus shows a new disease dynamic in ... this reason, the German National Academy of Sciences Leopoldina, ... and the Union of the German Academies of Sciences ... epidemic today. , In the statement the academies call ...
Breaking Biology News(10 mins):S-equol supplements associated with improved measures of reproductive health in postmenopausal women 2Scientists 'must not become complacent' when assessing pandemic threat from flu viruses 2Academies call for consequences from the Ebola virus epidemic 2Academies call for consequences from the Ebola virus epidemic 3Academies call for consequences from the Ebola virus epidemic 4Academies call for consequences from the Ebola virus epidemic 5
(Date:10/22/2014)... Hill, SC (PRWEB) October 22, 2014 ... expansion of its cardiovascular pharmacogenetics menu, which enables ... patient outcomes. With PCLS’s evidence-based results, healthcare ... needs and optimize their therapy, while minimizing risks ... In the U.S., according to the FDA [1] ...
(Date:10/22/2014)... , Oct. 22, 2014 /PRNewswire/ - iCo Therapeutics ... today announced next steps for its Oral Amphotericin ... from its in vitro work involving ... iCo now plans to complete pre clinical studies ... initial Phase 1A clinical trial, utilizing approximately $700,000 ...
(Date:10/22/2014)... DIEGO and HONG KONG ... innovative rare disease therapeutics enterprise, announced today that rare ... the company as vice president, research. Dr. McKew brings ... including key leadership positions at the National Institutes of ... its acquisition by Wyeth). Dr. McKew will lead aTyr,s efforts ...
(Date:10/20/2014)... 2014 Convey Computer , the ... from Iowa State University won first place in the ... Convey HC-2ex, the team’s solution achieved the highest overall ... the second place finisher. , Experts from all segments ... month long challenge, using a variety of design tools, ...
Breaking Biology Technology:PCLS Announces Expansion of Cardiovascular Pharmacogenetic Testing Menu 2PCLS Announces Expansion of Cardiovascular Pharmacogenetic Testing Menu 3iCo Therapeutics Announces Advancement of Oral Amphotericin B Program 2iCo Therapeutics Announces Advancement of Oral Amphotericin B Program 3aTyr Pharma Appoints John C. McKew, Ph.D., as Vice President, Research 2aTyr Pharma Appoints John C. McKew, Ph.D., as Vice President, Research 3Team from Iowa State Wins 2014 MemoCODE Design Contest Using Convey HC-2ex 2Team from Iowa State Wins 2014 MemoCODE Design Contest Using Convey HC-2ex 3
Cached News: